- Future Students
- Current Students
- About Notre Dame
- Staff & Future Staff
- Research & Centres
- Careers Service
- Community & Development
Professor John Eisman AO
Associate Dean, Clinical Leadership and Research
Phone: 02 8204 4450
John Eisman AO (MB BS, PhD, FRACP) is Associate Dean of Clinical Leadership and Research at Notre Dame’s Sydney School of Medicine. He is also Professor of Medicine (Conjoint) of the University of New South Wales, a Staff Endocrinologist at St. Vincent’s Hospital in Sydney and Director, Clinical Translation and Advanced Education, Garvan Institute of Medical Research. From 1984 to December 2011 he was Director of the Osteoporosis & Bone Biology at the Garvan Institute of Medical Research. His medical and basic science training was in Sydney and Melbourne with post-doctoral studies in Madison, Wisconsin and Bern, Switzerland.
Professor Eisman initiated and has run the Bone and Calcium clinic at St Vincent’s Hospital and the Dubbo Osteoporosis Epidemiology Study since their inception more than 20 years ago.
Professor Eisman was Editor-in-Chief of the Journal of Bone and Mineral Research, is a past member of the Board of the International Bone and Mineral Society and of the Council of the American Society for Bone and Mineral Research. He is a co-founder and past-President of the Australia and New Zealand Bone and Mineral Society. Professor Eisman chaired the inaugural Australian National Health Priority Action Council’s National Arthritis and Musculoskeletal Conditions Advisory Group and co-chaired its successor, the Australian Better Arthritis and Osteoporosis Expert Advisory Committee. He is currently co-chair of the NSW Health Agency for Clinical Innovation in Musculoskeletal conditions and chair of the American Society for Bone and Mineral Research (ASBMR) International Task Force on Osteoporotic Fracture.
The focus of Professor Eisman’s research is the epidemiology and genetics of osteoporosis, encompassing population, family and twin studies as well as molecular and cellular mechanisms for gene effects.
His major commitment and focus is translating osteoporosis research findings to real improvements in health care delivery to the general community through the education of patients and their doctors.